$RGNT

2 stories mentioning RGNTUpdated 15d ago

Every FINWIRES story that references RGNT, newest first.

Regentis Biomaterials Gets Approval for Cartilage Product Manufacturing Process From European Regulator

Regentis Biomaterials (RGNT) has obtained approval from the European Notified Body to manufacture its knee cartilage repair product GelrinC using its next-generation solvent-free manufacturing process, the company said Wednesday.The manufacturing process increases production yield fivefold and improves efficiency and scalability, the company said.Regentis prepares to commercially launch the product in Europe, it said.Price: $2.59, Change: $+0.09, Percent Change: +3.56%

$RGNT

Wire51d ago

Top Midday Gainers

Regentis Biomaterials (RGNT) said Monday it plans to begin European surgeon training activities in Q3 ahead of the commercial rollout of its GelrinC in knee cartilage repair.Shares soared over 130%, with more than 97.7 million shares traded intraday, compared with a daily average of about 27,000.J.M. Smucker (SJM) reported better-than-expected fiscal Q4 results on Tuesday, while the food producer's full-year earnings outlook came in above Wall Street's estimates at the midpoint.Shares climbed 9.6% following a rise in intraday trading volume to over 3.3 million from a daily average of about 1.9 million.Oil-Dri of America (ODC) reported a jump in fiscal Q3 earnings and revenue late Monday.Shares jumped 14%, with intraday trading volume rising to more than 166,000 from a daily average of about 67,000.Price: $2.99, Change: $+1.71, Percent Change: +133.59%

$ODC$RGNT$SJM

Track with the FINWIRES app suite

FolioX

Track RGNT in your portfolio

WheelAI

Analyze RGNT options with the wheel strategy

StockInsider

See market sentiment on RGNT